Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Beckers

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
European Journal of Endocrinology|January 21, 2015
Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrenceStephan Petersenn, Albert Beckers, Diego Ferone, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Distinguishing benign from pathogenic duplications involving <i>GPR101</i> and <i>VGLL1</i>-adjacent enhancers in the clinical setting with the bioinformatic tool POSTREGiampaolo Trivellin, Víctor Sánchez-Gaya, Alexia Grasso, et al.
NPJ Genomic Medicine|January 15, 2026
Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTREGiampaolo Trivellin, Víctor Sánchez-Gaya, Alexia Grasso, et al.
Endocrine Reviews|April 8, 2022
Clinical Biology of the Pituitary AdenomaShlomo Melmed, Ursula B Kaiser, M Beatriz Lopes, et al.
Endocrine-Related Cancer|March 15, 2018
Pheochromocytomas and pituitary adenomas in three patients with <i>MAX</i> exon deletionsAdrian F Daly, Emilie Castermans, Lindsey Oudijk, et al.
Endocrine-Related Cancer|March 11, 2016
Screening for GPR101 defects in pediatric pituitary corticotropinomasGiampaolo Trivellin, Ricardo R Correa, Maria Batsis, et al.
Frontiers in Endocrinology|September 15, 2023
The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the <i>aryl hydrocarbon receptor interacting protein</i> (AIP) geneLaurent Vroonen, Albert Beckers, Severine Camby, et al.
European Journal of Endocrinology|June 6, 2019
Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinomaEva C Coopmans, Sebastiaan W F van Meyel, Kay J Pieterman, et al.
Endocrine-Related Cancer|April 1, 2011
Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutationChiara Villa, Maria Stefania Lagonigro, Flavia Magri, et al.
European Journal of Endocrinology|April 9, 2005
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5Leo J Hofland, Joost van der Hoek, Richard Feelders, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
European Journal of Endocrinology|January 21, 2015
Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrenceStephan Petersenn, Albert Beckers, Diego Ferone, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Distinguishing benign from pathogenic duplications involving <i>GPR101</i> and <i>VGLL1</i>-adjacent enhancers in the clinical setting with the bioinformatic tool POSTREGiampaolo Trivellin, Víctor Sánchez-Gaya, Alexia Grasso, et al.
NPJ Genomic Medicine|January 15, 2026
Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTREGiampaolo Trivellin, Víctor Sánchez-Gaya, Alexia Grasso, et al.
Endocrine Reviews|April 8, 2022
Clinical Biology of the Pituitary AdenomaShlomo Melmed, Ursula B Kaiser, M Beatriz Lopes, et al.
Endocrine-Related Cancer|March 15, 2018
Pheochromocytomas and pituitary adenomas in three patients with <i>MAX</i> exon deletionsAdrian F Daly, Emilie Castermans, Lindsey Oudijk, et al.
Endocrine-Related Cancer|March 11, 2016
Screening for GPR101 defects in pediatric pituitary corticotropinomasGiampaolo Trivellin, Ricardo R Correa, Maria Batsis, et al.
Frontiers in Endocrinology|September 15, 2023
The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the <i>aryl hydrocarbon receptor interacting protein</i> (AIP) geneLaurent Vroonen, Albert Beckers, Severine Camby, et al.
European Journal of Endocrinology|June 6, 2019
Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinomaEva C Coopmans, Sebastiaan W F van Meyel, Kay J Pieterman, et al.
Endocrine-Related Cancer|April 1, 2011
Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutationChiara Villa, Maria Stefania Lagonigro, Flavia Magri, et al.
European Journal of Endocrinology|April 9, 2005
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5Leo J Hofland, Joost van der Hoek, Richard Feelders, et al.
Pageof 18